WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced its plans to release its second quarter 2024 financial results and provide a corporate update on Thursday, August 1, 2024.
The company will issue its Q2 2024 press release at 7:30 a.m. Eastern Time, followed by a conference call and webcast at 8:45 a.m. Eastern Time. Interested parties can register for the conference call through this link, and the live webcast will be accessible via the Investors section of Arbutus’ website at www.arbutusbio.com.
For those unable to attend the live event, an archived webcast will be available on the Arbutus website after the conference. This update offers a crucial opportunity for investors and analysts to gain insights into the company’s financial health and strategic plans for the near future.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.